ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced prostate cancer: GDC-1261 trial begins
Disease control Not yet recruitingThis study tests a new drug, GDC-1261, in 260 people with advanced or metastatic prostate cancer that has worsened despite prior treatment. The goal is to check the drug's safety, find the best dose, and see if it can slow the cancer. Participants must continue standard hormone t…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New prostate cancer drug aims to block hormones without heart risks
Disease control Not yet recruitingThis study tests a new drug called teverelix DP in 40 men with advanced prostate cancer. The goal is to safely lower testosterone to castrate levels using a specific dosing schedule. Participants receive injections on day 1 and then every 6 weeks. Results will help design a large…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for advanced prostate cancer: drug cocktail trial launches
Disease control Not yet recruitingThis study tests two experimental drugs, QLC5508 and QLH12016, alone or with standard hormone therapies (abiraterone or enzalutamide) in 212 men with advanced prostate cancer that has spread. The goal is to find safe doses and see if the combinations shrink tumors or lower PSA le…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC